CME Group (NASDAQ:CME) Price Target Raised to $266.00 at JPMorgan Chase & Co.

CME Group (NASDAQ:CME) had its price target lifted by JPMorgan Chase & Co. from $262.00 to $266.00 in a research note released on Thursday,Benzinga reports. They currently have an underweight rating on the financial services provider’s stock.

Several other equities research analysts have also commented on the stock. Bank of America upped their price target on shares of CME Group from $201.00 to $209.00 in a report on Wednesday, December 10th. Royal Bank Of Canada upped their target price on CME Group from $295.00 to $302.00 and gave the stock a “sector perform” rating in a research note on Thursday. UBS Group reiterated a “neutral” rating on shares of CME Group in a research report on Tuesday, January 6th. Rothschild & Co Redburn upped their price objective on CME Group from $297.00 to $300.00 and gave the stock a “neutral” rating in a research report on Thursday, November 6th. Finally, The Goldman Sachs Group cut their target price on shares of CME Group from $265.00 to $264.00 and set a “sell” rating for the company in a report on Wednesday, January 14th. Nine equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have given a Sell rating to the stock. According to data from MarketBeat.com, CME Group currently has an average rating of “Hold” and an average target price of $295.82.

CME Group Stock Up 0.9%

Shares of CME stock opened at $297.38 on Thursday. CME Group has a fifty-two week low of $239.70 and a fifty-two week high of $302.20. The firm has a market capitalization of $107.24 billion, a PE ratio of 26.65, a P/E/G ratio of 3.32 and a beta of 0.27. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.03. The stock’s 50-day simple moving average is $276.48 and its 200-day simple moving average is $272.84.

CME Group (NASDAQ:CME) last issued its earnings results on Wednesday, February 4th. The financial services provider reported $2.77 EPS for the quarter, beating analysts’ consensus estimates of $2.75 by $0.02. CME Group had a return on equity of 14.65% and a net margin of 62.45%.The firm had revenue of $1.65 billion for the quarter, compared to analyst estimates of $1.64 billion. During the same quarter in the prior year, the firm earned $2.52 earnings per share. CME Group’s revenue for the quarter was up 8.1% on a year-over-year basis. Equities analysts expect that CME Group will post 10.49 earnings per share for the current year.

Insider Activity at CME Group

In related news, CEO Terrence A. Duffy sold 25,000 shares of the business’s stock in a transaction on Thursday, December 11th. The shares were sold at an average price of $269.55, for a total value of $6,738,750.00. Following the completion of the sale, the chief executive officer owned 65,804 shares of the company’s stock, valued at approximately $17,737,468.20. The trade was a 27.53% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director William R. Shepard acquired 251 shares of the firm’s stock in a transaction on Tuesday, December 30th. The shares were bought at an average cost of $278.37 per share, for a total transaction of $69,870.87. Following the completion of the acquisition, the director owned 258,710 shares of the company’s stock, valued at approximately $72,017,102.70. This represents a 0.10% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Corporate insiders own 0.30% of the company’s stock.

Institutional Trading of CME Group

Several institutional investors have recently modified their holdings of the stock. Jessup Wealth Management Inc boosted its holdings in CME Group by 0.5% in the 2nd quarter. Jessup Wealth Management Inc now owns 7,969 shares of the financial services provider’s stock worth $2,197,000 after buying an additional 36 shares during the last quarter. First Horizon Advisors Inc. lifted its position in shares of CME Group by 0.7% in the second quarter. First Horizon Advisors Inc. now owns 5,269 shares of the financial services provider’s stock valued at $1,453,000 after acquiring an additional 36 shares in the last quarter. MBM Wealth Consultants LLC lifted its position in shares of CME Group by 2.7% in the second quarter. MBM Wealth Consultants LLC now owns 1,422 shares of the financial services provider’s stock valued at $392,000 after acquiring an additional 37 shares in the last quarter. West Family Investments Inc. boosted its stake in shares of CME Group by 1.2% in the third quarter. West Family Investments Inc. now owns 3,062 shares of the financial services provider’s stock worth $827,000 after acquiring an additional 37 shares during the last quarter. Finally, Asset Dedication LLC increased its position in shares of CME Group by 64.9% during the fourth quarter. Asset Dedication LLC now owns 94 shares of the financial services provider’s stock worth $26,000 after purchasing an additional 37 shares in the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

CME Group News Summary

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: Q4 results and record annual figures: CME posted Q4 EPS of $2.77 and revenue of ~$1.65B, with record 2025 annual revenue of $6.5B and all-time-high average daily volume in Q4 — fundamental beat that supports revenue resilience and margin strength. CME Group Q4 Earnings and Revenues Top Estimates, ADV Rises Y/Y
• Positive Sentiment: Management guidance and strategy: Management said fee adjustments could lift revenue ~1%–1.5% and reiterated plans to expand 24/7 crypto and securities clearing — a structural growth lever if adoption ramps. CME targets 1%-1.5% revenue lift; expanding 24/7 crypto
• Positive Sentiment: Morgan Stanley maintains Buy: A Wall Street analyst reiterated a Buy / Overweight view citing CME’s resilient fee-based franchise and underappreciated structural growth, supporting medium‑term upside. Morgan Stanley maintains Buy
• Neutral Sentiment: RBC raises price target modestly to $302 (sector perform): a small lift in analyst valuation but not a clear catalyst given the modest upside. RBC raises PT to $302
• Neutral Sentiment: Raymond James trims price target slightly to $310 but keeps Outperform — minimal change to the investment thesis. Raymond James adjusts PT to $310
• Neutral Sentiment: CEO says firm is exploring a proprietary token and tokenized cash pilots (with Google) to enable faster collateral movement and potential 24/7 trading — strategically important but execution, regulatory and adoption risks leave near-term impact uncertain. CME exploring issuing token
• Negative Sentiment: JPMorgan keeps an Underweight rating and has a $266 target (below current levels), signaling downside risk if volumes or product adoption slow relative to expectations. JPMorgan maintains Underweight, PT $266
• Negative Sentiment: Analyst caution / valuation note: a Seeking Alpha piece argues quality doesn’t automatically justify a buy today — a reminder that valuation and long-term growth execution should be assessed before adding exposure. CME Group: Quality Shines Through, But It Doesn’t Mean To Buy

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.